Last reviewed · How we verify
Mitoquinone
At a glance
| Generic name | Mitoquinone |
|---|---|
| Also known as | MitoQ, mitoquinol |
| Sponsor | D'Or Institute for Research and Education |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- A Double-Blind, Parallel, Randomized Comparison of Two Doses of MitoQ and Placebo for the Treatment of Patients With Raised Liver Enzymes Due to Hepatitis C (Phase 2)
- Mitochondrial Antioxidant Therapy to Resolve Inflammation in Ulcerative Colitis (Mini-MARVEL): A Phase 2b Feasibility Randomised Placebo Controlled Trial of Oral MitoQ in Mild-tomoderately Active Paed (Phase 2)
- Effects of Mitochondrial-targeted Antioxidant on Carotid Artery Endothelial Function and Brain Blood Flow in Mild Cognitive Impairment (MCI) Patients (NA)
- Mitochondrial Targeted Antioxidant Supplementation and Diastolic Function in Healthy Men and Women (NA)
- An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate as Prophylaxis for Development of Severe Viral Illness (Phase 1)
- The Influence of Race and MitoQ Supplementation on Skin Perfusion in the Cold (NA)
- Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease (Phase 4)
- Concentration of Mitoquinone Mesylate in Skeletal Muscle After a Single Oral Dose of MitoQ (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |